Research Nester has released a report titled “Auto-Injector Market: Global Demand Analysis & Opportunity Outlook 2030” which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, along with the impact of COVID-19 and a detailed discussion on the latest trends and future opportunities that are associated with the growth of the market.
The Asthma and Allergy Foundation of America (AAFA), in one of its statistics, stated that allergic conditions in the United States is one of the most common health issues that affects both adult and children. Moreover, anaphylaxis to food is estimated to result in 30,000 emergency room visits.
The statistics portray the growing concerns for the rising cases of allergic diseases worldwide and therefore the need for auto-injectors amongst these patients. For the treatment of allergic diseases such as, anaphylaxis, doctors prescribe epinephrine auto-injectors, as it has to be known to be an effective solution for the cure of the disease. Moreover, diabetes patients are required to inject insulin, which is also driving the need for auto-injectors. Such factors are therefore anticipated to drive the growth of the global auto-injector market.
The global auto-injector market is anticipated to grow with a CAGR of 13.9% during the forecast period, i.e., 2021-2030. The market is estimated to garner a revenue of USD 11354.6 Million by the end of 2030, up from a revenue of USD 3117.4 Million in the year 2020. The market is segmented by region into North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. By the end of 2030, the market in North America is anticipated to garner the largest market revenue of USD 4404.5 Million.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
The global auto-injector market is segmented by drug type into epinephrine, insulin, Rebif, and others. In the year 2020, amongst all these segments, the epinephrine segment registered the largest revenue of USD 857.2 Million, and is further expected to touch a revenue of USD 3230.8 Million by the end of 2030. On the other hand, based on type, the market is segmented into disposable auto-injector, and reusable auto-injector, out of which, the disposable auto-injector segment is projected to grow with the highest CAGR of 14% during the forecast period.
However, the availability of low-cost alternatives is one of the major factors projected to hinder the market growth in the coming years.
This report also provides the existing competitive scenario of some of the key players of the global auto-injector market, which includes company profiling of Pfizer Inc., BD, Adamis Pharmaceuticals Corporation, Biogen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Antares Pharma, Inc., Sanofi S.A., Ypsomed AG, SHL Medical AG, and others.
The profiling enfolds key information of the companies which comprises of business overview, products and services, key financials and recent news and developments. Conclusively, the report titled “Auto-Injector Market: Global Demand Analysis & Opportunity Outlook 2030”, analyses the overall global auto-injector industry to help new entrants to understand the details of the market. In addition to that, this report also guides existing players looking for expansion and major investors looking for investment in the global auto-injector market in the near future.
About Research Nester
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]